Leading Mass Spec Alphalyse is a specialized CRO with a long track record in mass spectrometry for protein analysis, including LC-MS-based MRM under GMP. This positions them well for pharma partners needing rigorous analytical validation and regulatory-compliant release testing.

GMP MRM Advantage They are reportedly the only CRO certified to offer LC-MS-based MRM analysis under GMP for release testing, presenting a unique selling point to biopharma companies seeking compliant, high-sensitivity impurity and host cell protein analysis.

Expansion Through Partnerships Recent collaboration with 89bio signals growth through joint assay development and validation, suggesting active outreach opportunities with biopharmaceuticals in liver and cardiometabolic spaces seeking robust analytical support.

Targeted HCP Expertise Strong focus on host cell protein analysis and impurity profiling, including development of orthogonal MS methods to list HCPs and amounts, aligning with biopharma needs for quality by design and regulatory documentation.

Scale and Capability Fit Revenue in the small-to-mid market range and a service portfolio spanning analytical characterization, peptide mapping, and complex sample quantification indicate fit for mid-size biotech firms and early-stage biotechs seeking scalable analytical CRO support.